Mar 20 |
GenScript Losses Shrink On Strong Growth For Cancer Cell Therapy
|
Mar 19 |
Legend Biotech files automatic mixed securities shelf
|
Mar 19 |
Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Report
|
Mar 17 |
30 Biggest Biotechnology Companies in the World
|
Mar 15 |
CARVYKTI® (ciltacabtagene autoleucel) Receives Recommendation from the U.S. FDA Oncologic Drugs Advisory Committee for Earlier Treatment of Patients with Relapsed/Refractory Multiple Myeloma
|
Mar 15 |
Johnson & Johnson wins FDA AdCom backing for Carvykti label expansion
|
Mar 15 |
Legend Biotech: AdCom Documents Shed Light On Carvykti's Problems (Downgrade)
|
Mar 13 |
Beauty Health Posts Upbeat Sales, Joins SIGA Technologies, MaxCyte And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
|
Mar 12 |
Legend Biotech Corporation (NASDAQ:LEGN) Q4 2023 Earnings Call Transcript
|
Mar 11 |
Legend Biotech Corporation (LEGN) Q4 2023 Earnings Call Transcript
|